Perspective Therapeutics to Participate in Upcoming December Conferences
Stocks in this Quantisnow insightHealth Care
Historical context for CATX
Across the 4 sessions after earlier CATX headlines, the stock closed higher 2 times and lower 1 times, with a median move of 3.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CATX | SPY |
|---|---|---|---|
| Nov 11, 2025 | Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results | +0.0% | +0.2% |
| Oct 31, 2025 | Perspective Therapeutics to Participate in Upcoming November Conferences | +3.4% | +0.3% |
| Oct 24, 2025 | Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results | +3.8% | +0.8% |
| Oct 20, 2025 | Perspective Therapeutics Presents Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the ESMO Congress 2025 | -29.0% | +1.0% |
Keep researching CATX
- What is Earnings call?A conference call or webcast where company management discusses quarterly results and guidance and takes questions from analysts.
- Earnings season calendarEarnings season starts about two weeks after each quarter ends and runs roughly six weeks. Learn the timing, BMO and AMC releases, whisper numbers and guidance.
- CATX earnings historyPast Perspective Therapeutics Inc. earnings releases, newest first.
- CATX financial statementsRevenue, profit, cash flow and balance sheet from Perspective Therapeutics Inc.'s SEC filings.
Quantisnow market dataAMEX
CATX
Perspective Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for CATX
Full CATX profile on Quantisnow Follow CATX and get a push notification the moment its next story breaks.